Cargando…
VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease
Several symptomatic treatments for Parkinson's disease (PD) are currently available. Still, the challenge today is to find a therapy that might reduce degeneration and slow down disease progression. The identification of pathogenic mutations in familial Parkinsonism (fPD) associated to the mono...
Autores principales: | Eleuteri, Simona, Albanese, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928206/ https://www.ncbi.nlm.nih.gov/pubmed/31920908 http://dx.doi.org/10.3389/fneur.2019.01272 |
Ejemplares similares
-
Screening for VPS35 mutations in Parkinson's disease
por: Sheerin, Una-Marie, et al.
Publicado: (2012) -
VPS35, the Retromer Complex and Parkinson’s Disease
por: Williams, Erin T., et al.
Publicado: (2017) -
VPS35, the core component of the retromer complex, and Parkinson's disease
por: Luo, Ai‐Di, et al.
Publicado: (2021) -
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
por: Tsika, Elpida, et al.
Publicado: (2014) -
VPS35 Parkinson mutation impairs autophagy via WASH
por: Zavodszky, Eszter, et al.
Publicado: (2014)